Bulgaria
· Delayed Price · Currency is BGN Biodit AD Statistics
Total Valuation
Biodit AD has a market cap or net worth of BGN 12.74 million. The enterprise value is 13.21 million.
| Market Cap | 12.74M |
| Enterprise Value | 13.21M |
Important Dates
The last earnings date was Friday, November 29, 2024.
| Earnings Date | Nov 29, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Biodit AD has 14.82 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 14.82M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 1.14% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 13.26 |
| PB Ratio | 1.06 |
| P/TBV Ratio | 1.06 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -48.38 |
| EV / Sales | 13.74 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -17.82 |
Financial Position
The company has a current ratio of 4.45, with a Debt / Equity ratio of 0.08.
| Current Ratio | 4.45 |
| Quick Ratio | 1.49 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.22 |
| Interest Coverage | -5.28 |
Financial Efficiency
Return on equity (ROE) is -2.25% and return on invested capital (ROIC) is -1.17%.
| Return on Equity (ROE) | -2.25% |
| Return on Assets (ROA) | -1.15% |
| Return on Capital (ROIC) | -1.17% |
| Revenue Per Employee | 137,286 |
| Profits Per Employee | -39,000 |
| Employee Count | 10 |
| Asset Turnover | 0.07 |
| Inventory Turnover | 0.27 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.76% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -36.76% |
| 50-Day Moving Average | 0.96 |
| 200-Day Moving Average | 1.22 |
| Relative Strength Index (RSI) | 39.36 |
| Average Volume (20 Days) | 2,254 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biodit AD had revenue of BGN 961,000 and -273,000 in losses. Loss per share was -0.02.
| Revenue | 961,000 |
| Gross Profit | 493,000 |
| Operating Income | -243,000 |
| Pretax Income | -295,000 |
| Net Income | -273,000 |
| EBITDA | -137,500 |
| EBIT | -243,000 |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 441,000 in cash and 904,000 in debt, giving a net cash position of -463,000 or -0.03 per share.
| Cash & Cash Equivalents | 441,000 |
| Total Debt | 904,000 |
| Net Cash | -463,000 |
| Net Cash Per Share | -0.03 |
| Equity (Book Value) | 12.02M |
| Book Value Per Share | 0.81 |
| Working Capital | 1.84M |
Cash Flow
In the last 12 months, operating cash flow was -724,000 and capital expenditures -17,000, giving a free cash flow of -741,000.
| Operating Cash Flow | -724,000 |
| Capital Expenditures | -17,000 |
| Free Cash Flow | -741,000 |
| FCF Per Share | -0.05 |
Margins
Gross margin is 51.30%, with operating and profit margins of -25.29% and -28.41%.
| Gross Margin | 51.30% |
| Operating Margin | -25.29% |
| Pretax Margin | -30.70% |
| Profit Margin | -28.41% |
| EBITDA Margin | -14.31% |
| EBIT Margin | -25.29% |
| FCF Margin | n/a |
Dividends & Yields
Biodit AD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -2.14% |
| FCF Yield | -5.81% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Biodit AD has an Altman Z-Score of 11.94.
| Altman Z-Score | 11.94 |
| Piotroski F-Score | n/a |